Dengue Treatment Market Trend Analysis Research by Type (Vaccines, Acetaminophen), By Route Of Administration (Parenteral, Oral), By Drug Class (Nsaids, Antibiotics, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospital, Specialty Clinics, Home Healthcare)and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Global Forecast to 2034.
Feb-2025 Formats | PDF | Category: Pharma and Healthcare | Delivery: 24 to 72 Hours
“The Dengue Treatment industry is expected to expand from $2.34 Billion in 2025 to $ 4.56 Billion in 2034, with a compound annual growth rate of 11.3%. “
Dengue Treatment Market: Overview and Growth in the Upcoming Year
The Dengue Treatment Market has experienced significant growth in recent years, with the market expected to continue growing in the future. The virus, transmitted by mosquitoes, causes flu-like symptoms like high fever, severe headache, joint and muscle pain, and rash. Early detection and good medical care can help ease symptoms and avoid complications. Dengue is currently treated with supportive care, including rest, water, and pain-relieving medicine.
The global Dengue treatment market is experiencing steady growth due to rising global prevalence of the disease, with Asia-Pacific having the highest number of cases, followed by Latin America and Africa, thereby driving the market’s growth.
Dengue therapy research has made significant progress, but market expansion is hindered by a lack of specific antiviral medications, limited healthcare access in developing nations, and the development of resistant Dengue strains.
The market expansion potential is significant due to the focus on preventive measures like vector control, vaccination programs, and public health education, as well as the development of novel treatment approaches and targeted medicines.
For Insights Consultancy’s latest market intelligence study, “Global Dengue Treatment Market 2025, Growth Opportunities, and Forecast,” provides a comprehensive analysis of the Pharma and healthcare industry. The report includes demand analysis, industry insights, competition intelligence, and a customer database. It also offers strategic insights into future trends, growth determinants, supplier landscape, demand landscape, CAGR, and pricing analysis. The study also includes Porter’s Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps’ Analysis, Market Attractiveness Analysis, BPS Analysis, and Ecosystem Analysis.
Do you think, if this report could be of your interest? If yes, request Sample Copy of this Report: https://www.forinsightsconsultancy.com/reports/request-sample-dengue-treatment-market
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 110+ is available for purchase to all the interested stakeholders.
Top Companies Covered In This Report:
- Pfizer Inc.
- Hoffmann-La Roche Ltd.
- Merck & Co Inc.
- Sanofi S.A.
- Abbott Laboratories
- Novartis International AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim GmbH
- Hetero Labs Limited
- Sun Pharmaceutical Industries Limited
- Reddy’s Laboratories Limited
- Cipla Incorporated
- Emergent BioSolutions Inc.
- Bharat Biotech International Limited
- Inovio Pharmaceuticals Inc.
- Gennova Biopharmaceuticals Ltd.
- ABIVAX S.A.
- Cadila Healthcare Limited
- Biological E. Limited
For instance, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korea-based manufacturer of pharmaceutical products, launched XAFTY, a groundbreaking broad-spectrum antiviral designed to treat multiple viral infections, including COVID-19, and dengue fever.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2034, Y-o-Y growth rate, and CAGR):
Segment by Type
- Vaccines
- Acetaminophen
Segment byRoute Of Administration
- Parenteral
- Oral
Segment byDrug Class
- Nsaids
- Antibiotics
- Corticosteroids
Segment byDistribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Segment by End-User
- Hospitals
- Specialty Clinics
- Home Healthcare
Subsegments
By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen
Regional Deep-dive Analysis:
The report provides in-depth qualitative and quantitative data on the Dengue Treatment Market for all of the regions and countries listed below:
- North America includes the United States, Canada, and Mexico.
- Europe includes Germany, France, Italy, the United Kingdom, Scandinavia, Benelux, Russia, and the rest of Europe.
- Asia-Pacific includes Japan, South Korea, India, China, Southeast Asia, and Australia.
- South America (including Brazil, Argentina, and the rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa)
Each country is studied in detail, and the study includes qualitative and quantitative analysis of the Dengue Treatment Market in that country.
North America
Dengue fever is less common in North America, limiting the dengue treatment market. However, cases have increased due to more people visiting endemic areas. Prevention strategies include mosquito control and public awareness campaigns, while treatment focuses on supportive care to alleviate symptoms like fever, discomfort, and thirst.
Europe
Dengue fever epidemics are rare in Europe, mainly in southern tourist sites. Recent cases have been documented in Spain, France, and Italy. The treatment industry in Europe prioritizes early detection and fast treatment to avoid serious consequences, following WHO recommendations for dengue fever management.
Asia Pacific
The Asia Pacific region, including India, Indonesia, and Thailand, is the most affected by dengue fever globally. The region offers diverse treatment options including antipyretics, pain relievers, and intravenous fluids. Severe cases may require hospitalization. Governments are working to improve mosquito control techniques and raise awareness about dengue prevention.
Middle East
Dengue fever is a growing issue in the Middle East, with recent outbreaks in Saudi Arabia, Oman, and Yemen. The treatment market is expanding, with healthcare providers focusing on improving diagnostic skills and treatment availability to effectively manage the disease and prevent its spread.
Recent News:
- In May 2024, Johnson & Johnson (JNJ) revealed its definitive agreement to acquire Yellow Jersey Therapeutics (YJT), a wholly-owned subsidiary of Numab therapeutics, in an all-cash transaction valued at around USD1.25 billion. This strategic acquisition is poised to bolster JNJ’s growth trajectory by expanding its portfolio in the biopharmaceutical sector. By integrating YJT’s innovative pipeline and expertise, JNJ aims to enhance its capabilities in developing novel therapies, ultimately strengthening its position as a leader in the healthcare industry
- In August 2023, according to the article by the FDA, DENGVAXIA, a tetravalent live vaccine manufactured by Sanofi Pasteur, Inc., is indicated for the prevention of dengue disease caused by serotypes 1, 2, 3, and 4 of the dengue viruses. Approved for individuals aged 6 through 16 years, it is specifically targeted at those residing in endemic areas who have a laboratory-confirmed previous dengue infection. This vaccine represents a significant advancement in combatting dengue fever, offering targeted protection against multiple serotypes of the virus, thereby potentially reducing the incidence rate of dengue infections in vulnerable populations
- In February 2024, according to the article by Takeda Pharmaceutical Company Limited., the company committed to producing up to 50 million doses annually of QDENGA, the Dengue Tetravalent Vaccine (Live, Attenuated), accelerating Takeda’s goal of delivering 100 million doses per year by 2030. These multi-dose vials (MDVs) are designated to aid in government procurement for National Immunization Programs in endemic countries by 2030, facilitating broader access to dengue vaccination and contributing to global disease prevention efforts. Additionally, two live-attenuated dengue vaccines are in phase 3 developments which are, the TDV developed by Takeda and the LAV Delta 30 developed by NIH/Butantan Institute
- In July 2019, Hikma Pharmaceuticals Inc. and Civica Rx signed long-term agreement to minimize the future generic drug shortages in the US region this will help the company to expand their generics sales and to build a customer base which will increase the net revenue and sales
- In Novemeber 2019, Perrigo Company plc announced that their “Quitting is Better” therapy campaign has won a notable national award for the Best OTC Corporate Social Responsibility Campaign. The company won for innovation and strategic marketing by a panel of volunteer judges comprised of industry representatives that are members of the Consumer Healthcare Products Association (CHPA). This will increase the company profile in the global region
The research provides answers to the following key questions:
- What is the expected growth rate of the Dengue Treatment market from 2025-2034?
- What are the key driving forces shaping the market during the forecast period?
- Who are the major market vendors and what winning strategies have helped them occupy a strong foothold in the Dengue Treatment market?
- What are the prominent market trends influencing the market’s development?
Buy the Complete Report with an Impressive Discount (Up to 30% Off) @: https://www.forinsightsconsultancy.com/buy-now-dengue-treatment-market
Key insights provided by the report that could help you take critical strategic decisions?
- Regional reports analyse product/service consumption and market factors in each region.
- Reports highlight possibilities and dangers for suppliers in the Dengue Treatment business globally.
- The report identifies regions and sectors with the highest growth potential.
- It provides a competitive market ranking of major companies, as well as information on new product launches, partnerships, business expansions, and acquisitions.
- The report includes a comprehensive corporate profile with company overviews, insights, product benchmarks, and SWOT analysis for key market participants.
Customization: We can provide following things 1) On request more company profiles (competitors) 2) Data about particular country or region 3) We will incorporate the same with no additional cost (Post conducting feasibility).
Any Requirement Contact us: https://www.forinsightsconsultancy.com/contact-us/
Table of Contents
- Executive Summary
- Dengue Treatment Market Characteristics
- Dengue Treatment Market Trends And Strategies
- Dengue Treatment Market – Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- Global Dengue Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Dengue Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dengue Treatment Market Growth Rate Analysis
5.4. Global Dengue Treatment Historic Market Size and Growth, 2019 – 2024, Value ($ Billion)
5.5. Global Dengue Treatment Forecast Market Size and Growth, 2025- 2034, 2034F, Value ($ Billion)
5.6. Global Dengue Treatment Total Addressable Market (TAM)
- Dengue Treatment Market Segmentation
6.1. Global Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Vaccines
Acetaminophen
6.2. Global Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Parenteral
Oral
6.3. Global Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Nsaids
Antibiotics
Corticosteroids
6.4. Global Dengue Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Dengue Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Hospital
Specialty Clinics
Home Healthcare
6.6. Global Dengue Treatment Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Live Attenuated Vaccines
Recombinant Vaccines
Inactivated Vaccines
6.7. Global Dengue Treatment Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Oral Acetaminophen
Intravenous Acetaminophen
- Dengue Treatment Market Regional And Country Analysis
7.1. Global Dengue Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
7.2. Global Dengue Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Asia-Pacific Dengue Treatment Market
8.1. Asia-Pacific Dengue Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
8.3. Asia-Pacific Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
8.4. Asia-Pacific Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- China Dengue Treatment Market
9.1. China Dengue Treatment Market Overview
9.2. China Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
9.3. China Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
9.4. China Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
- India Dengue Treatment Market
10.1. India Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
10.2. India Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
10.3. India Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Japan Dengue Treatment Market
11.1. Japan Dengue Treatment Market Overview
11.2. Japan Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
11.3. Japan Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
11.4. Japan Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Australia Dengue Treatment Market
12.1. Australia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
12.2. Australia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
12.3. Australia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Indonesia Dengue Treatment Market
13.1. Indonesia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
13.2. Indonesia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
13.3. Indonesia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- South Korea Dengue Treatment Market
14.1. South Korea Dengue Treatment Market Overview
14.2. South Korea Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
14.3. South Korea Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
14.4. South Korea Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Western Europe Dengue Treatment Market
15.1. Western Europe Dengue Treatment Market Overview
15.2. Western Europe Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
15.3. Western Europe Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
15.4. Western Europe Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- UK Dengue Treatment Market
16.1. UK Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
16.2. UK Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
16.3. UK Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Germany Dengue Treatment Market
17.1. Germany Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
17.2. Germany Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
17.3. Germany Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- France Dengue Treatment Market
18.1. France Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
18.2. France Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
18.3. France Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Italy Dengue Treatment Market
19.1. Italy Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
19.2. Italy Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
19.3. Italy Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Spain Dengue Treatment Market
20.1. Spain Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
20.2. Spain Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
20.3. Spain Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Eastern Europe Dengue Treatment Market
21.1. Eastern Europe Dengue Treatment Market Overview
21.2. Eastern Europe Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
21.3. Eastern Europe Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
21.4. Eastern Europe Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Russia Dengue Treatment Market
22.1. Russia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
22.2. Russia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
22.3. Russia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- North America Dengue Treatment Market
23.1. North America Dengue Treatment Market Overview
23.2. North America Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
23.3. North America Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
23.4. North America Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- USA Dengue Treatment Market
24.1. USA Dengue Treatment Market Overview
24.2. USA Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
24.3. USA Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
24.4. USA Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Canada Dengue Treatment Market
25.1. Canada Dengue Treatment Market Overview
25.2. Canada Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
25.3. Canada Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
25.4. Canada Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- South America Dengue Treatment Market
26.1. South America Dengue Treatment Market Overview
26.2. South America Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
26.3. South America Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
26.4. South America Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Brazil Dengue Treatment Market
27.1. Brazil Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
27.2. Brazil Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
27.3. Brazil Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Middle East Dengue Treatment Market
28.1. Middle East Dengue Treatment Market Overview
28.2. Middle East Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
28.3. Middle East Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
28.4. Middle East Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Africa Dengue Treatment Market
29.1. Africa Dengue Treatment Market Overview
29.2. Africa Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
29.3. Africa Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
29.4. Africa Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Dengue Treatment Market Competitive Landscape And Company Profiles
30.1. Dengue Treatment Market Competitive Landscape
30.2. Dengue Treatment Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Dengue Treatment Market Other Major And Innovative Companies
31.1. Novartis International AG
31.2. GlaxoSmithKline plc
31.3. Takeda Pharmaceutical Company Limited
31.4. Boehringer Ingelheim GmbH
31.5. Hetero Labs Limited
31.6. Sun Pharmaceutical Industries Limited
31.7. Dr. Reddy’s Laboratories Limited
31.8. Cipla Incorporated
31.9. Emergent BioSolutions Inc.
31.10. Bharat Biotech International Limited
31.11. Inovio Pharmaceuticals Inc.
31.12. Gennova Biopharmaceuticals Ltd.
31.13. ABIVAX S.A.
31.14. Cadila Healthcare Limited
31.15. Biological E. Limited
- Global Dengue Treatment Market Competitive Benchmarking And Dashboard
- Key Mergers And Acquisitions In The Dengue Treatment Market
- Recent Developments In The Dengue Treatment Market
- Dengue Treatment Market High Potential Countries, Segments and Strategies
35.1 Dengue Treatment Market In 2034 – Countries Offering Most New Opportunities
35.2 Dengue Treatment Market In 2034 – Segments Offering Most New Opportunities
35.3 Dengue Treatment Market In 2034 – Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
- Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. For Insights Consultancy
36.6. Copyright And Disclaimer
Select PDF License
Single User: $3499
Multiple Users: $4499
Corporate Users: $5499
